CEO: Joe Conroy
Chairman: Stephen Neal
Number of partners: 350+ Number of lawyers: 1,100+
Cooley’s lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies with an emphasis on technology, life sciences and other high-growth industries. Clients partner with Cooley on transforma- tive deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley maintains an environment of inclusion and is proud to be one of FORTUNE’s “100 Best Companies to Work For.” The firm has 1,100+ lawyers across 16 offices in the US, Asia and Europe.
Main Areas of Practice:
Key corporate strengths include capital markets, M&A, emerging companies, venture capital, tech transactions, fund formation and life sciences corporate partnering and licensing. Cooley is continuously ranked as the most active law firm representing issuers and underwriters in IPOs in the life sciences and tech sectors. Cooley’s leadership in this area gives the firm deep industry-specific experience as corporate counsel to high-growth companies.
Key litigation strengths include advertising, antitrust, appellate, class actions, employment, insurance and reinsurance, intellectual property litigation, international arbitration, ITC, patent, privacy and cybersecurity, product liability, regulatory, securities, tax, trademark and copyright, trade secrets and white collar defense and investigations. Cooley’s global trial practice has won verdicts and awards worth billions of dollars and protected market share for innovative clients against competitors, consumers and regulators. The team includes five partners who are Fellows of the American College of Trial Lawyers and 20+ former assistant US attorneys and Department of Justice lawyers.
Cooley has one of the largest full-service IP practices of any law firm in the US. The firm serves as IP counsel to 1,000+ companies across all industry sectors worldwide. Key strengths include IP litigation across all major venues; patent counseling and prosecution; trademark, copyright and advertising; and due diligence, licensing and strategic transactions. Cooley is a top law firm at the Patent Trial and Appeal Board and has one of the most active IP litigation practices in the US including numerous trial wins. The firm also has one of the largest life sciences and medical device patent teams of any law firm in the US. In the past year, Cooley’s global IP team filed 8,000+ patent and trademark applications worldwide. The team has also led 1,000+ investor-side and company-side due diligence reviews in high-value deals, financings and transactions.
Key strengths include antitrust and competition, communications, financial services, government contracts, insurance, healthcare, education, international trade, media and securities. Cooley has significant experience representing clients in investigations and matters involving the SEC, DOJ, FTC, FCC, ITC, DOD, DOE, EPA, NSC, EEOC, Treasury and other federal agencies.
Antitrust & Competition:
Providing a full range of counseling, litigation, agency representation and arbitration services, Cooley handles all aspects of antitrust/competition law and trade regulation matters for Fortune 500 corporations, as well as growing companies, in virtually every sector of the economy.
Cooley advised on 685+ completed public offerings since 2015, leading all law firms for VC-backed technology and life sciences IPOs for the last 15 years and as company counsel for US venture-backed IPOs, according to IPO Vital Signs.
Cooley’s cyber/data/privacy practice is a large, global team of lawyers focusing on all aspects of cyber, data protection and privacy. The firm represents clients across all industries, which range from emerging to Fortune 500 companies, on the full spectrum of privacy, cybersecurity and information management issues. Additionally, Cooley has successfully litigated a range of cases involving privacy and data breach issues, including class actions and government enforcement actions, on behalf of our clients.
Cooley represents 6,000+ private companies across all industries. Over the past decade, Cooley has represented thousands of technology, life sciences and other high-growth businesses with all aspects of their formation and development. The firm is involved in 1,000+ financings annually and is ranked among the most active firms in the US for number of private company equity financing deals in 2019 by Pitchbook.
Intellectual Property Litigation:
Cooley’s IP litigators win cases across the US and UK in every conceivable forum and manner. They are experienced in all types of IP cases including patent, Section 337 investigations, trademark, trade dress, trade secret, copyright, false advertising, domain name and licensing matters. With nearly 600 IP cases in the last five years, including 500+ patent cases, Cooley is widely acknowledged as one of the top IP litigation practices in the US.
With 1,600+ public and private life science company clients worldwide, Cooley is the leading deal firm across all aspects of corporate and transactional practices, including M&A, IPOs, financings and private equity work. Cooley represents more than 50% of the NASDAQ Biotechnology Index and is widely known as a best-in-class firm for handling corporate partnering and licensing transactions.
Since 2015, Cooley has handled 1,000+ M&A transactions, with an aggregate value of $395+ billion, making the practice one of the most active in the country, particularly for technology and life sciences companies.
Cooley counsels public companies in high-stakes, complex business and litigation matters across the globe. The firm represents 1,200+ public companies and serves as principal corporate governance and securities counsel for 185+ publicly companies. The team has extensive experience and familiarity with federal and state securities laws, which enables Cooley to be strategic advisors to both seasoned and newly public companies.
Cooley has one of the most active practices for the defense of issuers in shareholder litigation in the US. With 500+ representations over the past decade, the firm’s securities litigation clients include a diverse range of businesses and individuals, including startups and Fortune 500 companies.
Cooley is counsel to 500+ investment fund organizations. The firm completed 300+ fund closings in 2019, raising over $28+ billion in capital commitments.
Cooley’s world-class transactional team has guided leading private equity sponsors in some of the market’s largest and most complex transactions. The team advised on 50+ private equity sponsor-side deals in the last five years and 90+ growth equity sponsor-side deals in the last two years.
The firm has a market reputation for innovative, tax-efficient structuring of business transactions and effective resolution of significant tax controversies.
The team’s diverse capabilities allow Cooley to explore all facets of real estate development and craft the best business-oriented solutions for clients. The firmassists owners, operators, developers, lenders, tenants and institutional investors and advisors with a wide variety of real property and related capital markets transactions as well as litigation.
The firm’s technology transactions team combines the elements of an intellectual property practice with a commercial transactions practice and is trained in best practices in these disciplines, enabling them to meet the demands of a fast-evolving, increasingly global environment. Many of the firm’s lawyers have “in house” legal or business experience with technology companies; all are capable dealmakers who have an aptitude for, and keen interest in, the technologies that help their clients thrive.